EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics

Abdelrahman Abaza, Faten Sid Idris, Humna Anis Shaikh, Ilma Vahora, Kiran Prasad Moparthi, Majdah T Al Rushaidi, Meghana Reddy Muddam, Omobolanle A Obajeun, Arturo P Jaramillo, Safeera Khan

Cureus · 02.09.2023

DOI: 10.7759/cureus.44582 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 02.09.2023. Verfasst von Abdelrahman Abaza und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cancer therapeuticsclinical trialsimmune check-point inhibitorimmunotherapypathology

Autor:innen und Institutionen

  • Pathology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Pediatrics, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • General Surgery, Saint George's University School of Medicine, Chicago, USA.
  • College of Medicine, Sri Venkata Sai (SVS) Medical College, Mahabubnagar, IND.
  • General Practice, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Psychology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Zitieren

APA

Abaza, A., Sid Idris, F., Anis Shaikh, H., Vahora, I., Moparthi, K. P., Al Rushaidi, M. T., Muddam, M. R., Obajeun, O. A., Jaramillo, A. P., & Khan, S. (2023). Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics. Cureus. https://doi.org/10.7759/cureus.44582

Vancouver

Abaza A, Sid Idris F, Anis Shaikh H, Vahora I, Moparthi KP, Al Rushaidi MT, et al. Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics. Cureus. 2023. doi:10.7759/cureus.44582

BibTeX
@article{Abaza2023,
  author = {Abaza, Abdelrahman and Sid Idris, Faten and Anis Shaikh, Humna and Vahora, Ilma and Moparthi, Kiran Prasad and Al Rushaidi, Majdah T and Muddam, Meghana Reddy and Obajeun, Omobolanle A and Jaramillo, Arturo P and Khan, Safeera},
  title = {Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.44582}
}
Kostenlos starten →